Register to receive a free U.S. Market for Interventional Cardiology Devices report synopsis and brochure
Lloyd Klein, MD, Professor of Medicine at Rush Medical College in Chicago, and Director of the Clinical Cardiology Associates in Chicago, has written a new op-ed piece on cath lab and radiation safety. It’s a fascinating read and we hope you enjoy it. The following is an excerpt.
Interventional cardiologists take our responsibility to improve patient quality of life and increase the likelihood of survival in heart diseases seriously, and we are willing to accept personal risk to practice our profession. Perhaps this is why, for the past 30 years or so, interventionalists never made a fuss about the health problems we face as a result of our work in fluoroscopy labs.
It’s not that this issue didn’t exist in the past. In fact, the question of how radiation might negatively affect physicians has been well documented for decades. Even when I was a medical student, it was a known fact that radiologists developed fluoroscopy-related illnesses such as leukemia, thyroid disease and cataracts at a higher incidence than others. Lead shielding was developed to obviate this concern.
What began to raise my awareness of this issue as a cardiology fellow was the extremely heavy and burdensome lead shielding I had to wear to protect myself from radiation exposure. After a couple of cases in the cath lab, my neck and back would hurt all day long! Yet, in the past, when younger physicians tried to discuss this problem with the older physicians, their attitude, to a large extent, was that if working in these conditions really bothered you, then you were entering the wrong field.
Lloyd Klein, MD, is Professor of Medicine, Rush Medical College in Chicago, and Director, Clinical Cardiology Associates in Chicago and Melrose Park, Ill. He is also a member of the Organization for Occupational Radiation Safety in Interventional Fluoroscopy.
For Further Information
More on the interventional cardiology market in the U.S. can be found in the report published by iData entitled U.S. Market for Interventional Cardiology Devices. This report also covers the U.S. market segments for bare-metal and drug-eluting stents, PTCA and cutting balloons, balloon-inflation devices, interventional coronary catheters, interventional coronary guidewires, coronary embolic protection devices, coronary atherectomy devices, coronary thrombectomy devices, coronary chronic total occlusion crossers, introducer sheaths, coronary vascular closure devices, diagnostic coronary catheter and guidewires, intravascular ultrasound catheters, and optical coherence tomography catheters.
The iData series on the market for interventional cardiology devices covers the U.S., Japan, Brazil, and 15 countries in Europe. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.
To find out more about U.S interventional cardiology market data or procedure data, register online or email us at [email protected] for a U.S. Market for Interventional Cardiology Devices report brochure and synopsis.
About Procedure Tracker
Additional procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by country, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.